Drug
Aklmrna
Aklmrna: highest development phase Phase 1, developed by Klothea Bio Inc. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Klothea Bio Inc
Trials
| Drug | Phase | Indication |
|---|---|---|
| aKLmRNA (AKL003) NCT07544420 | Phase 1 | Aging |
Latest
No recent events.
Follow Aklmrna on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.